Systemic Therapy of Non-Resectable Metastatic Melanoma

In advanced metastatic melanoma (non-resectable stage III/IV), the prognosis still remains poor, with median survival times between six and twelve months. Systemic therapeutic approaches for metastatic melanoma include chemotherapy, immunotherapy, immunochemotherapy, small molecules and targeted the...

Descripción completa

Detalles Bibliográficos
Autores principales: Orouji, Azadeh, Goerdt, Sergij, Utikal, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835112/
https://www.ncbi.nlm.nih.gov/pubmed/24281101
http://dx.doi.org/10.3390/cancers2020955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835112/
https://www.ncbi.nlm.nih.gov/pubmed/24281101
http://dx.doi.org/10.3390/cancers2020955

Ejemplares similares